1. Bladder Cancer Canada has identified awareness and outreach to be a critical priority in 2021. We know that 80,000 Canadians are living with bladder cancer and that our community base consists of approximately 10% of these patients. BCC is strategizing new communications and awareness initiatives to target newer audiences that currently may not be aware of BCC or even bladder cancer in general. This includes the launch of a bladder cancer blog in December of 2020 and a podcast for Bladder Cancer Awareness Month in May 2021. BCC also continues to discover impactful stories of young patients through social media, particularly Facebook and Instagram, which is helping us reach a much younger Canadian demographic.
2. Many pharmaceutical companies that collaborate and keep in dialogue with Bladder Cancer Canada continue to make great progress in improving the quality of care for bladder cancer patients in Canada. Most recently, this includes Health Canada’s approval of Verity Pharmaceuticals’ production and distribution of the BCG Russian strain (which will be available to Canadians this year), as well as the approval of EMD Serono/Pfizer’s Avelumab as maintenance therapy in Metastatic Bladder Cancer. Bladder Cancer Canada worked closely with these pharmaceutical companies in the distribution of this important information to our patient community, and providing BCC spokespeople and patient stories for media opportunities, as requested. BCC also worked with AstraZeneca on the New Normal Same Cancer campaign, to raise awareness amongst Canadians that their cancer advocacy efforts, treatment and care must continue despite the global impact of COVID-19.
3. Despite the impact and challenges of the COVID pandemic, the Bladder Cancer Forum with the Canadian Clinical Research Group was held virtually in Canada in February 2021, following two other translational research meetings held in 2020 (April and October). This forum will be the foundational work of the Canadian Bladder Cancer Research Network, which launched in April 2020.
4. Canada is showing great progress in organ preservation for bladder cancer, through two international trials, one on BCG unresponsive disease (Dr. Peter Black) and the other on bladder preservation for muscle invasive disease (Dr. Wes Kassouf).
5. Bladder Cancer Canada continues to fund research as one of its three organizational pillars. Bladder Cancer Canada’s research grants are funding the following two studies: ctDNA-FGFR status as a predictive biomarkerfor FGFR targeted therapy (Dr. Bernie Eigl) and Computer-aided Discovery of a Specific Inhibitor of Notch-2 in Bladder Cancer (Dr. Peter Black). The following two research studies are also being funded by Bladder Cancer Canada, in partnership with the Canadian Urological Association Scholarship Foundation: Exploring the tumour immune environment of bladder cancer (Dr. Robert Siemens, Tizianna Cotechini, Charles Hindmarch and Parvin Mousavi) and Role of bisphenol compounds (BPA and BPS) in the progression of bladder cancer (Drs. Stephane Bolduc, Martin Pelletier, Frederic Pouliot). Bladder Cancer Canada is allocating $100K for research grants in 2021, which will be matched by the Canadian Urological Association (CUA) for a total of $200K. These funds will be divided into four $25K grants and two $50K grants adjudicated by a panel of peers.
Related Post
-
By Tawny Barratt | Comments are ClosedThis issue is all about how we continue to support patients through free programs and services, including co-founder Jack Moon’s “Why I Walk” message. Subscribe today! Registration is now open for the 2021 Bladder CancerRead more
-
By Tawny Barratt | 0 commentBy: Tawny Barratt Read time: 16 minutes Thanks so much for joining us during Bladder Cancer Awareness month! There are currently 80,000 Canadians currently living with a bladder cancer diagnosis and 12,000 more will beRead more
-
By Tawny Barratt | 0 commentDATE: MAY 17, 2021 TORONTO – On behalf of the Board of Directors of Bladder Cancer Canada, Survivor and Volunteer Board Chair Ferg Devins is delighted to announce the appointment of Michelle Colero to the positionRead more
-
By Tawny Barratt | 0 commentRead time: 2 minutes We were so pleased to see one of our new Peer Support Volunteers, Gervais Fournier, featured in this New Normal, Same Cancer news story, seen last month in the Le JournalRead more
-
By Tawny Barratt | 0 commentAs seen in www.healthinsights.ca. There are 80,000 Canadians living with bladder cancer, and many of them are younger than you’d think. Here’s one family’s story about why awareness and early detection are critical in savingRead more
-
By Tawny Barratt | 0 commentBy: Tom Eremondi Read time: 3.5 minutes Admittedly old school, Gerry Ross’ approach to dealing with a local walk sponsor nurtured and enhanced the relationship to a surprising level. This story, however, dates back aboutRead more
-
By Tawny Barratt | Comments are ClosedUncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that is affecting us all on some level. Many members of our bladder cancer community are directing questions our way aboutRead more
-
By Tawny Barratt | Comments are Closed(The following content is sourced from various sites advising on the coronavirus. For more information, please see the end of this article for additional resources. Photo Credit: CDC) As news of the coronavirus (COVID-19) continues toRead more
-
By Tawny Barratt | Comments are ClosedIn a recent press release, Janssen Pharmaceutical Companies of Johnson & Johnson have announced that they have received approval from Health Canada for BALVERSA™ (erdafitinib), the first FGFR Kinase inhibitor for the treatment of patientsRead more
-
By Tawny Barratt | Comments are ClosedBladder Cancer Canada was recently reviewed by Charity Intelligence, an independent organization that researches Canadian charities so that donors can be well informed and give intelligently. Of the 750 charities that Charity Intelligence has reviewed,Read more
-
By Tawny Barratt | Comments are ClosedIMPORTANT UPDATE – March 9, 2020 Bladder Cancer Canada (BCC) and its Medical Advisory Board were advised by Merck Canada in November 2019 that they would continue to face challenges in the supply of the TICERead more
-
By Tawny Barratt | Comments are ClosedTORONTO, CANADA (May 15, 2020) – This year, 12,000 Canadians will be diagnosed with bladder cancer, and for many of these Canadians, the global development of COVID-19 will impact bladder cancer diagnoses, treatments and outcomes.Read more
-
By Tawny Barratt | Comments are ClosedPosted July 30, 2020. Watch Webinar In this webinar, Dr. Girish Kulkarni set a foundation of the basics of clinical trials (what they are, how are they designed, terminology, etc.). He then delved deeper into aspectsRead more
-
By Tawny Barratt | Comments are ClosedMany of us at Bladder Cancer Canada are saddened by the news of the recent passing of Paul Unterman, a volunteer and former board member, to bladder cancer. Paul volunteered on the board of directorsRead more
-
By Tawny Barratt | Comments are ClosedAt a recent Board of Director’s meeting, and on behalf of the board and the Medical Advisory and Research Boards, BCC chair Ferg Devins was pleased to present the Founders’ Award to his friend andRead more
-
By Tawny Barratt | Comments are ClosedWe met up with our Executive Director Dr. Dionne Duncan and her good friend Mel on the waterfront in beautiful Port Credit, Ontario. Dionne and Mel demonstrate how we can support each other this SeptemberRead more
-
By Tawny Barratt | Comments are ClosedIt is hard to believe, but it is once again time for our Bladder Cancer Awareness Walk, and due to the precautions that we are taking because of COVID -19, the walk will be virtual this year. Over the pastRead more
-
By Tawny Barratt | Comments are ClosedDear Bladder Cancer Canada friend, I know that you (or someone you care about) has been touched by bladder cancer. That’s not surprising, considering that 80,000 Canadians are currently living with bladder cancer and 12,000Read more
Leave a Comment